GM Advisory Group’s AbbVie ABBV Stock Holding History

GM Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.61M	Sell	7,400 -348	-4%	-$77.2K	0.06%	124
2025 Q4	$1.77M	Buy	7,748 +1,152	+17%	+$262K	0.07%	119
2025 Q3	$1.53M	Sell	6,596 -235	-3%	-$47.9K	0.06%	117
2025 Q2	$1.27M	Buy	6,831 +3,164	+86%	+$588K	0.06%	130
2025 Q1	$768K	Buy	3,667 +77	+2%	+$15K	0.04%	147
2024 Q4	$638K	Buy	3,590 +1,056	+42%	+$194K	0.04%	153
2024 Q3	$500K	Buy	2,534 +276	+12%	+$51.5K	0.03%	162
2024 Q2	$387K	Sell	2,258 -50	-2%	-$8.28K	0.03%	169
2024 Q1	$420K	Buy	2,308 +70	+3%	+$12.1K	0.03%	158
2023 Q4	$347K	Sell	2,238 -200	-8%	-$29.2K	0.03%	165
2023 Q3	$363K	Sell	2,438 -730	-23%	-$107K	0.03%	143
2023 Q2	$427K	Sell	3,168 -169	-5%	-$24.8K	0.04%	139
2023 Q1	$532K	Buy	3,337 +371	+13%	+$56.7K	0.05%	120
2022 Q4	$479K	Buy	2,966 +295	+11%	+$45.2K	0.05%	117
2022 Q3	$358K	Sell	2,671 -90	-3%	-$12.9K	0.05%	133
2022 Q2	$423K	Sell	2,761 -291	-10%	-$44.5K	0.07%	123
2022 Q1	$495K	Hold	3,052	–	–	0.06%	124
2021 Q4	$413K	Sell	3,052 -600	-16%	-$70.9K	0.04%	140
2021 Q3	$394K	Sell	3,652 -911	-20%	-$104K	0.04%	140
2021 Q2	$514K	Buy	4,563 +663	+17%	+$74.7K	0.05%	126
2021 Q1	$422K	Sell	3,900 -13,541	-78%	-$1.45M	0.05%	129
2020 Q4	$1.87M	Sell	17,441 -639	-4%	-$61.4K	0.25%	50
2020 Q3	$1.58M	Buy	18,080 +550	+3%	+$51.8K	0.24%	50
2020 Q2	$1.72M	Buy	+17,530	New	+$1.54M	0.32%	46

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GM Advisory Group's ABBV Position: Q1 2026 in Review

GM Advisory Group reduced its AbbVie (ABBV) stake by 4.5% in Q1 2026, selling an estimated $77.2K and leaving 7,400 shares worth $1.61M. The position accounts for 0.06% of the portfolio, ranked #124.

GM Advisory Group first reported a position in ABBV in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.87M in Q4 2020. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

GM Advisory Group held 7,400 shares of AbbVie worth $1.61M as of Q1 2026.
GM Advisory Group sold 348 AbbVie shares in Q1 2026, an estimated $77.2K.
AbbVie made up 0.06% of GM Advisory Group's portfolio in Q1 2026, its #124 holding.
GM Advisory Group first reported a position in AbbVie in Q2 2020 and has held it in 24 quarters since.
GM Advisory Group's AbbVie position peaked at $1.87M in Q4 2020.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.